Prognostic impact of postoperative infection in patients with pancreatic cancer: A multicenter cohort study
Author:
Okada KenjiroORCID, Uemura KenichiroORCID, Ohge Hiroki, Iseki MasahiroORCID, Mizuma Masamichi, Shinkawa HirojiORCID, Takahata Risa, Aoki TakuORCID, Makino KentaORCID, Arai Hiroki, Miyake ToruORCID, Takeda Shigeru, Yokoyama Yasuyuki, Yaguchi YoshihisaORCID, Kobayashi MinakoORCID, Matsuda Akihisa, Shiomi Hisanori, Watanabe ManabuORCID, Akagi Shinji, Inoue Toru, Tanemoto Kazuo, Maruyama HiroshiORCID
Reference22 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018 2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014 3. Current state of surgical management of pancreatic cancer;Hackert;Cancers (Basel),2011 4. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial;Jang;Ann Surg,2018 5. A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact;Kondo;Eur J Cancer,2021
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|